Travere Therapeutics Inc. (tvtx 2.25 03/01/29)
13F holders, Q4 2025 (December 31)5holders +1
2new positions
1sold out
$1.42avg. 13F price*
At the end of Q4 2025, 5 institutions reported holding Travere Therapeutics Inc. (tvtx 2.25 03/01/29) in their 13F filings, up 1 from Q3 2025. 2 opened new positions and 1 sold out. The largest holders were Polar Capital Holdings Plc ($3.5M), New York State Common Retirement Fund ($1.1M) and NewEdge Advisors, LLC ($30K).
- Company
- Travere Therapeutics Inc. (tvtx 2.25 03/01/29)
- CUSIP
- 89422GAA5
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $3.6M |
| Exits | 1 | $7.2M |
All 13F filers, Q3 2025 → Q4 2025: 2,521,000 shares bought and 7,533,000 shares sold, net −5,012,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Polar Capital Holdings Plc | 0.02% | New | 2,500,000 | $3.5M |
| New York State Common Retirement Fund | 0.00% | Reduce -59.5% | 800,000 | $1.1M |
| NewEdge Advisors, LLC | 0.00% | New | 21,000 | $30K |
| &partners | 0.00% | No change | 16,000 | $23K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 2,000 | $3K |
"% of holder's portfolio" is TRAVERE THERAPEUTICS INC (TVTX 2.25 03/01/29)'s weight in each manager's 13F, not the share of Travere Therapeutics Inc. (tvtx 2.25 03/01/29) the manager owns.